Medtronic (MDT) Competitors

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends, community ranking and analyst recommendations.

Does the media prefer ABT or MDT?

In the previous week, Abbott Laboratories had 2 more articles in the media than Medtronic. MarketBeat recorded 36 mentions for Abbott Laboratories and 34 mentions for Medtronic. Abbott Laboratories' average media sentiment score of 1.26 beat Medtronic's score of 1.08 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	31 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	23 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer ABT or MDT?

Medtronic received 650 more outperform votes than Abbott Laboratories when rated by MarketBeat users. Likewise, 75.75% of users gave Medtronic an outperform vote while only 69.70% of users gave Abbott Laboratories an outperform vote.

Company	Underperform	Outperform
Abbott Laboratories	Outperform Votes 934 69.70%	Underperform Votes 406 30.30%
Medtronic	Outperform Votes 1584 75.75%	Underperform Votes 507 24.25%

Is ABT or MDT a better dividend stock?

Abbott Laboratories pays an annual dividend of $2.20 per share and has a dividend yield of 1.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.2%. Abbott Laboratories pays out 66.9% of its earnings in the form of a dividend. Medtronic pays out 94.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has increased its dividend for 53 consecutive years and Medtronic has increased its dividend for 48 consecutive years.

Is ABT or MDT more profitable?

Abbott Laboratories has a net margin of 13.99% compared to Medtronic's net margin of 12.06%. Abbott Laboratories' return on equity of 20.18% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	13.99%	20.18%	10.84%
Medtronic	12.06%	13.68%	7.67%

Do analysts prefer ABT or MDT?

Abbott Laboratories presently has a consensus target price of $130.07, indicating a potential upside of 12.38%. Medtronic has a consensus target price of $95.36, indicating a potential upside of 8.39%. Given Abbott Laboratories' stronger consensus rating and higher possible upside, research analysts plainly believe Abbott Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.75
Medtronic	1 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.44

Do institutionals & insiders believe in ABT or MDT?

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 1.1% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.2% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has better valuation and earnings, ABT or MDT?

Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$40.11B	5.00	$5.72B	$3.29	35.18
Medtronic	$32.36B	3.49	$3.68B	$2.96	29.72

Which has more risk and volatility, ABT or MDT?

Abbott Laboratories has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500.

Summary

Abbott Laboratories beats Medtronic on 16 of the 22 factors compared between the two stocks.